REQUEST A DEMO
Total
USD $0.00
Search more companies

Hlb Pharmaceutical Co., Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Hlb Pharmaceutical Co., Ltd. Profile Updated: May 16, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Hlb Pharmaceutical Co., Ltd. is based in South Korea, with the head office in Namyangju. The company operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on April 23, 1998. There are currently 185 (2025) people employed by Hlb Pharmaceutical Co., Ltd.. In 2025, the company reported a net sales revenue increase of 49.97%. There was a total growth of 8.07% in Hlb Pharmaceutical Co., Ltd.’s total assets over the same period. In 2025, Hlb Pharmaceutical Co., Ltd.’s net profit margin increased by 0.75%.

Headquarters
27 Gyeonggang-Ro
Namyangju; Gyeonggi; Postal Code: 12244

Contact Details: Purchase the Hlb Pharmaceutical Co., Ltd. report to view the information.

Website: http://www.c-tri.co.kr

Basic Information
Total Employees:
Purchase the Hlb Pharmaceutical Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Hlb Pharmaceutical Co., Ltd. report to view the information.
Registered Capital:
Purchase the Hlb Pharmaceutical Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Hlb Pharmaceutical Co., Ltd. report to view the information.
Incorporation Date:
April 23, 1998
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Outside Director
Ownership Details
Purchase this report to view the information.
10.5%
Purchase this report to view the information.
3.4%
Purchase this report to view the information.
1.5%
Subsidiaries
(주)신화어드밴스
(주)아이오쏠라
(주)엘에스케이인베스트먼트
Company Performance
Financial values in the chart are available after Hlb Pharmaceutical Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
49.97%
Total Operating Revenue
54.61%
Operating Profit
N/A
EBITDA
80.19%
Net Profit/Loss for the Period
126.35%
Total Assets
8.07%
Total Equity
7.51%
Operating Profit Margin
N/A
Net Profit Margin
0.75%
Return on Equity (ROE)
1.91%
Debt / Equity
2.74%
Quick Ratio
0.14%
Cash Ratio
-0.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?